FDA Clears Phase 1b/2 Trial of CAR T-Cell Therapy C-CAR168 for Refractory Progressive Multiple Sclerosis NeurologyLiveSingle CAR-T Treatment Shows Promise for Relieving Multiple Sclerosis Symptoms, Trial Finds Medical DialoguesChimeric Antigen Receptor T-cell (CAR-T) Therapy in Autoimmune Diseases: A Narrative Review Cureus‘Good First Try’: In Vivo CAR T for Neuro Autoimmune Disease MedscapeCAR T-cell therapy tested for rheumatoid arthritis to eliminate disease-driving B cells mid-day.com
FDA Clears Phase 1b/2 Trial of CAR T-Cell Therapy C-CAR168 for Refractory Progressive Multiple Sclerosis NeurologyLiveSingle CAR-T Treatment Shows Promise for Relieving Multiple Sclerosis Symptoms, Trial Finds Medical DialoguesChimeric Antigen Receptor T-cell (CAR-T) Therapy in Autoimmune Diseases: A Narrative Review Cureus‘Good First Try’: In Vivo CAR T for Neuro Autoimmune Disease MedscapeCAR T-cell therapy tested for rheumatoid arthritis to eliminate disease-driving B cells mid-day.com
